LON:INDV - Indivior Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started GBX 49.02 +0.16 (+0.33 %) (As of 05/24/2019 03:15 PM ET)Previous CloseGBX 48.86Today's RangeGBX 48.80 - GBX 51.1852-Week RangeGBX 20.98 - GBX 504.60Volume3.14 million shsAverage Volume2.44 million shsMarket Capitalization£357.86 millionP/E Ratio1.44Dividend YieldN/ABetaN/A ProfileAnalyst RatingsChartInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence. The company's product pipeline focuses on treating opioid use disorder, alcohol use disorder, opiate overdose, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy analgesic products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia. Receive INDV News and Ratings via Email Sign-up to receive the latest news and ratings for INDV and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry Drugs - Generic Sub-IndustryN/A SectorMedical Current SymbolLON:INDV Previous Symbol CUSIPN/A CIKN/A Webhttp://indivior.com/ Phone+44-1753-217800Debt Debt-to-Equity Ratio223.31 Current Ratio1.79 Quick Ratio1.70Price-To-Earnings Trailing P/E Ratio1.44 Forward P/E Ratio9.80 P/E GrowthN/A Sales & Book Value Annual Sales£988 million Price / Sales0.36 Cash FlowGBX 145.76 per share Price / Cash Flow0.34 Book ValueGBX 18.20 per share Price / Book2.69Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees915 Outstanding Shares730,030,976Market Cap£357.86 million Next Earnings Date7/23/2019 (Estimated) OptionableNot Optionable Indivior (LON:INDV) Frequently Asked Questions What is Indivior's stock symbol? Indivior trades on the London Stock Exchange (LON) under the ticker symbol "INDV." When is Indivior's next earnings date? Indivior is scheduled to release their next quarterly earnings announcement on Tuesday, July 23rd 2019. View Earnings Estimates for Indivior. What price target have analysts set for INDV? 5 equities research analysts have issued 1 year target prices for Indivior's stock. Their predictions range from GBX 114 to GBX 398. On average, they anticipate Indivior's stock price to reach GBX 194.40 in the next twelve months. This suggests a possible upside of 296.6% from the stock's current price. View Analyst Price Targets for Indivior. What is the consensus analysts' recommendation for Indivior? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Indivior in the last year. There are currently 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Indivior. Has Indivior been receiving favorable news coverage? Press coverage about INDV stock has been trending negative recently, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Indivior earned a news sentiment score of -2.9 on InfoTrie's scale. They also gave media coverage about the specialty pharmaceutical company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the next several days. Who are some of Indivior's key competitors? Some companies that are related to Indivior include iKang Healthcare Group (KANG), Cambrex (CBM), HEXO (HEXO), Silk Road Medical (SILK), Clinigen Group (CLIN), Cardiovascular Systems (CSII), Coherus Biosciences (CHRS), Esperion Therapeutics (ESPR), Gossamer Bio (GOSS), Alector (ALEC), CareDx (CDNA), Rubius Therapeutics (RUBY), Nanosonics (NAN), Momenta Pharmaceuticals (MNTA) and Opko Health (OPK). What other stocks do shareholders of Indivior own? Based on aggregate information from My MarketBeat watchlists, some companies that other Indivior investors own include Bigblu Broadband (BBB), Directa Plus (DCTA), Futura Medical (FUM), Lakehouse (LAKE), Umicore (UMI), Aquila Services Group (AQSG), Benchmark (BMK), Bodycote (BOY), CityFibre Infrastructure (CITY) and Deltex Medical Group (DEMG). Who are Indivior's key executives? Indivior's management team includes the folowing people: Mr. Shaun Thaxter, CEO & Exec. DirectorMr. Mark Crossley, CFO & Exec. DirectorDr. Christian Heidbreder, Chief Scientific OfficerMr. Ingo Elfering, Chief Information & Innovation OfficerMr. Jason Thompson, VP of Investor Relations How do I buy shares of Indivior? Shares of INDV and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Indivior's stock price today? One share of INDV stock can currently be purchased for approximately GBX 49.02. How big of a company is Indivior? Indivior has a market capitalization of £357.86 million and generates £988 million in revenue each year. Indivior employs 915 workers across the globe. What is Indivior's official website? The official website for Indivior is http://indivior.com/. How can I contact Indivior? Indivior's mailing address is 103-105 Bath Road, SLOUGH, SL1 3UH, United Kingdom. The specialty pharmaceutical company can be reached via phone at +44-1753-217800. MarketBeat Community Rating for Indivior (LON INDV)Community Ranking: 3.3 out of 5 ( )Outperform Votes: 442 (Vote Outperform)Underperform Votes: 220 (Vote Underperform)Total Votes: 662MarketBeat's community ratings are surveys of what our community members think about Indivior and other stocks. Vote "Outperform" if you believe INDV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INDV will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/24/2019 by MarketBeat.com StaffFeatured Article: What is the NASDAQ Stock Market? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.